1. Home
  2. ONCO vs NURO Comparison

ONCO vs NURO Comparison

Compare ONCO & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • NURO
  • Stock Information
  • Founded
  • ONCO 2018
  • NURO 1996
  • Country
  • ONCO United States
  • NURO United States
  • Employees
  • ONCO N/A
  • NURO N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • NURO Medical/Dental Instruments
  • Sector
  • ONCO Health Care
  • NURO Health Care
  • Exchange
  • ONCO Nasdaq
  • NURO Nasdaq
  • Market Cap
  • ONCO 9.4M
  • NURO 8.2M
  • IPO Year
  • ONCO 2022
  • NURO N/A
  • Fundamental
  • Price
  • ONCO $0.54
  • NURO $4.38
  • Analyst Decision
  • ONCO
  • NURO
  • Analyst Count
  • ONCO 0
  • NURO 0
  • Target Price
  • ONCO N/A
  • NURO N/A
  • AVG Volume (30 Days)
  • ONCO 9.9M
  • NURO 19.9K
  • Earning Date
  • ONCO 04-10-2025
  • NURO 02-24-2025
  • Dividend Yield
  • ONCO N/A
  • NURO N/A
  • EPS Growth
  • ONCO N/A
  • NURO N/A
  • EPS
  • ONCO N/A
  • NURO N/A
  • Revenue
  • ONCO $1,870,605.00
  • NURO $3,767,764.00
  • Revenue This Year
  • ONCO N/A
  • NURO N/A
  • Revenue Next Year
  • ONCO N/A
  • NURO N/A
  • P/E Ratio
  • ONCO N/A
  • NURO N/A
  • Revenue Growth
  • ONCO N/A
  • NURO N/A
  • 52 Week Low
  • ONCO $0.32
  • NURO $2.66
  • 52 Week High
  • ONCO $21.40
  • NURO $4.73
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 43.36
  • NURO 67.35
  • Support Level
  • ONCO $0.53
  • NURO $4.16
  • Resistance Level
  • ONCO $0.70
  • NURO $4.39
  • Average True Range (ATR)
  • ONCO 0.06
  • NURO 0.06
  • MACD
  • ONCO 0.00
  • NURO 0.00
  • Stochastic Oscillator
  • ONCO 15.40
  • NURO 91.56

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About NURO NeuroMetrix Inc.

NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.

Share on Social Networks: